Frequencies of BCL2 and BCL6 translocations in representative chinese follicular lymphoma patients: Morphologic, immunohistochemical, and FISH analyses

Diagnostic Molecular Pathology

Volumn 21, Issue 4, 2012, Pages 234-240

  Pan, Yi ^a,b   Meng, Bin ^c   Sun, Baocun ^a,b   Guan, Bingxin ^c   Liang, Yan ^c   Wang, Huaqing ^a,b   Hao, Xishan ^a,b   Fu, Kai ^d  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b Therapeutic Center for Hematological Malignancies   (China)

^c SHANDONG UNIVERSITY   (China)

^d UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

BCL2; BCL6; Follicular lymphoma; translocation

Indexed keywords

COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN BCL 6;

ADULT; ARTICLE; CANCER MORPHOLOGY; CANCER PATIENT; CHINESE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; GENE AMPLIFICATION; GENE FREQUENCY; GENE TRANSLOCATION; GENETIC CORRELATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; IN SITU HYBRIDIZATION, FLUORESCENCE; LYMPHOMA, FOLLICULAR; MALE; MIDDLE AGED; NEOPLASM GRADING; ONCOGENE FUSION; PROTO-ONCOGENE PROTEINS C-BCL-2; TISSUE ARRAY ANALYSIS; TRANSLOCATION, GENETIC; TUMOR MARKERS, BIOLOGICAL;

EID: 84870253630     PISSN: 10529551     EISSN: 15334066     Source Type: Journal    
DOI: 10.1097/PDM.0b013e3182585c3c     Document Type: Article

References (32)

1. Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project. Ann Oncol. 1998;9:717-720. (Pubitemid 28394156)
2. Biagi JJ, Seymour JF. Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation. Blood. 2002;99:4265-4275. (Pubitemid 34627191)
3. Lymphoma Study Group of Japanese Pathologists. The World Health Organization classification of malignant lymphomas in Japan: incidence of recently recognized entities. Pathol Int. 2000; 50:696-702.
4. Ko YH, Kim CW, Park CS, et al. REAL classification of malignant lymphomas in the Republic of Korea: incidence of recently recognized entities and changes in clinicopathologic features. Hematolymphoreticular Study Group of the Korean Society of Pathologists. Revised European-American lymphoma. Cancer. 1998;83:806-812.
5. Sukpanichnant S, Sonakul D, Piankijagum A, et al. Malignant lymphoma in Thailand: changes in the frequency of malignant lymphoma determined from a histopathologic and immunophenotypic analysis of 425 cases at Siriraj Hospital. Cancer. 1998;83: 1197-1204. (Pubitemid 28419074)
6. Swerdlow SH, Campo E, Harris NL, et al. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC; 2008:220-226.
7. Montoto S, Lopez-Guillermo A, Colomer D, et al. Incidence and clinical significance of bcl-2/IgH rearrangements in follicular lymphoma. Leuk Lymphoma. 2003;44:71-76. (Pubitemid 36113831)
8. Peh SC, Shaminie J, Tai YC, et al. The pattern and frequency of t(14;18) translocation and immunophenotype in Asian follicular lymphoma. Histopathology. 2004;45:501-510. (Pubitemid 39524325)
9. Baccarelli A, Hirt C, Pesatori AC, et al. t(14;18) translocations in lymphocytes of healthy dioxin-exposed individuals from Seveso, Italy. Carcinogenesis. 2006;27:2001-2007. (Pubitemid 44530574)
10. Schwaenen C, Viardot A, Berger H, et al. Molecular Mechanisms in Malignant Lymphomas Network Project of the Deutsche Krebshilfe: microarray-based genomic profiling reveals novel genomic aberrations in follicular lymphoma which associate with patient survival and gene expression status. Genes Chromosomes Cancer. 2009;48:39-54.
11. Fu K, Weisenburger DD, Greiner TC, et al. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling. Blood. 2005;106:4315-4321. (Pubitemid 41775942)
12. Belaud-Rotureau M-A, Parrens M, Carrere N, et al. Interphase fluorescence in situ hybridization is more sensitive than BIOMED-2 polymerase chain reaction protocol in detecting IGH-BCL2 rearrangement in both fixed and frozen lymph node with follicular lymphoma. Hum Pathol. 2007;38:365-372. (Pubitemid 46096564)
13. Yanai S, Nakamura S, Takeshita M, et al. Translocation t(14;18)/IGH-BCL2 in gastrointestinal follicular lymphoma. Cancer. 2011; 6:2467-2477.
14. Fernandez AP, Sun Y, Raymond R, et al. FISH for MYC amplification and anti-MYC immunohistochemistry: useful diagnostic tools in the assessment of secondary angiosarcoma and atypical vascular proliferations. J Cutan Pathol. 2012;39:234-242.
15. Guo Y, Karube K, Kawano R, et al. Low-grade follicular lymphoma with t (14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances. Leukemia. 2005;19:1058-1063. (Pubitemid 40862019)
16. Matsumoto Y, Nomura K, Matsumoto S, et al. Detection of t(14;18) in follicular lymphoma by dual-color fluorescence in situ hybridization on paraffin-embedded tissue sections. Cancer Genet Cytogenet. 2004;150:22-26. (Pubitemid 38372197)
17. Sekiguchi N, Kobayashi Y, Yokota Y, et al. Follicular lymphoma subgrouping by fluorescence in situ hybridization analysis. Cancer Sci. 2005;96:77-82. (Pubitemid 40425382)
18. Gollub W, Stassek B, Huckhagel T, et al. BCL6-translocations affect the phenotype of follicular lymphomas only in the absence of t(14;18)IgH/BCL2. Anticancer Res. 2009;29:4649-4656.
19. Ott G, Katzenberger T, Lohr A, et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. Blood. 2002;99: 3806-3812. (Pubitemid 34534555)
20. Bosga-Bouwer AG, van Imhoff GW, Boonstra R, et al. Follicular lymphoma grade 3B includes 3 cytogenetically defined subgroups with primary t(14;18), 3q27, or other translocations: t(14;18) and 3q27 are mutually exclusive. Blood. 2003;101:1149-1154. (Pubitemid 36139390)
21. Bastard C, Deweindt C, Kerckaert JP, et al. LAZ3 rearrangements in non-Hodgkin's lymphoma: correlation with histology, immunophenotype, karyotype, and clinical outcome in 217 patients. Blood. 1994;83:2423-2427. (Pubitemid 24135832)
22. Lo Coco F, Ye BH, Lista F, et al. Rearrangements of the BCL6 gene in diffuse large cell non-Hodgkin's lymphoma. Blood. 1994;83: 1757-1759. (Pubitemid 24107897)
23. Otsuki T, Yano T, Clark HM, et al. Analysis of LAZ3 (BCL-6) status in B-cell non-Hodgkin's lymphomas: results of rearrangement and gene expression studies and a mutational analysis of coding region sequences. Blood. 1995;85:2877-2884.
24. Pittaluga S, Ayoubi TA, Wlodarska I, et al. BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas. J Pathol. 1996;179:145-150. (Pubitemid 26201581)
25. Herod JJ, Eliopoulos AG, Warwick J, et al. The prognostic significance of Bcl-2 and P53 expression in ovarian carcinoma. Cancer Res. 1996;56:2178-2184. (Pubitemid 26119922)
26. Cinatl J Jr, Cinatl J, Vogel JU, et al. Persistent human cytomegalovirus infection induces drug resistance and alteration of programmed cell death in human neuroblastoma cells. Cancer Res. 1998;58:367-372. (Pubitemid 28047081)
27. Seto M. Genetic and epigenetic factors involved in B cell lymphomagenesis. Cancer Sci. 2004;95:1-7.
28. Karube K, Ying G, Tagawa H, et al. BCL6 gene amplification/3q27 gain is associated with unique clinicopathological characteristics among follicular lymphoma without BCL2 gene translocation. Mod Pathol. 2008;21:973-978.
29. Aster JC, Longtine JA. Detection of BCL2 rearrangements in follicular lymphoma. Am J Pathol. 2002;160:759-763. (Pubitemid 34224564)
30. Papakonstantinou G, Verbeke C, Hastka J, et al. bcl-2 expression in non-Hodgkin's lymphomas is not associated with bcl-2 gene rearrangements. Br J Haematol. 2001;113:383-390. (Pubitemid 32523142)
31. Seite P, Hillion J, d'Agay MF, et al. BCL2 gene activation and protein expression in follicular lymphoma: a report on 64 cases. Leukemia. 1993;7:410-417. (Pubitemid 23093100)
32. Horsman DE, Okamoto I, Ludkovski O, et al. Follicular lymphoma lacking the t(14;18)(q32;q21): identification of two disease subtypes. Br J Haematol. 2003;120:424-433. (Pubitemid 36241498)